secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sintx Technologies, Inc. (SINT)
CIK:        0001269026
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0001641172-25-020513
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SINTX submits FDA 510(k) for silicon nitride foot/ankle implants, entering $750M market
--------------------------------------------------------------------------------

- Filed 510(k) for silicon nitride osteotomy wedges on July 22, 2025, targeting foot/ankle fusion.
- Foot/ankle fusion market valued at $750.5M, projected to reach $1.38B by 2032.
- Biomaterial track record: >50,000 spinal implants since 2008; antimicrobial & radiolucent properties.
- Implants to be manufactured at SINTX's FDA/ISO facility, distributed as SiNAPTIC Surgical (acquired July 1, 2025).
- Expected to drive revenue growth through hospital and ASC adoption with single-use instrumentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1269026/000164117225020513/0001641172-25-020513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1269026/000164117225020513/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer